AUTHENTERRA HEALTHCARE LLP

Overview

AUTHENTERRA HEALTHCARE LLP is an active pharmaceutical ingredient (API) supplier with 6 active FDA Type II Drug Master Files, covering AMITRAZ IP/BP; FLUNIXIN MEGLUMINE IP/BP/EP/USP; MANNITOL IP/BP/EP/USP; MARBOFLOXACIN IP/BP/EP; PRAZIQUANTEL IP/BP/EP/USP; TRICLABENDAZOLE IP/EP/BP/USP.

API / Drug Master Files

AUTHENTERRA HEALTHCARE LLP holds 6 active (6 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• TRICLABENDAZOLE IP/EP/BP/USPActive2026-01-24
• FLUNIXIN MEGLUMINE IP/BP/EP/USPActive2025-12-17
• AMITRAZ IP/BPActive2025-12-04
• MARBOFLOXACIN IP/BP/EPActive2025-12-04
• MANNITOL IP/BP/EP/USPActive2025-09-29
• PRAZIQUANTEL IP/BP/EP/USPActive2025-09-29

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to AUTHENTERRA HEALTHCARE LLP in our records. PharmaTek screens the full directory against live FDA enforcement data.